| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 781 | 496 | 670 | 562 | 3.213 | 4.142 |
| Total Income - EUR | - | - | - | - | 781 | 496 | 670 | 562 | 3.213 | 4.142 |
| Total Expenses - EUR | - | - | - | - | 917 | 366 | 166 | 1.529 | 1.441 | 2.856 |
| Gross Profit/Loss - EUR | - | - | - | - | -136 | 130 | 504 | -967 | 1.772 | 1.285 |
| Net Profit/Loss - EUR | - | - | - | - | -160 | 116 | 486 | -984 | 1.503 | 1.010 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Amd Oncology Services S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 9 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 779 | 56 | 544 | 234 | 1.056 | 2.967 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 374 | 0 | 0 | 0 | 130 | 1.264 |
| Cash | - | - | - | - | 405 | 56 | 544 | 234 | 926 | 1.703 |
| Shareholders Funds | - | - | - | - | -118 | 0 | 486 | -496 | 1.008 | 1.058 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 906 | 56 | 58 | 730 | 48 | 1.909 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Amd Oncology Services S.r.l.